WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.
Shared 1 month ago
12 views
Shared 1 month ago
11 views
Shared 1 month ago
18 views
Shared 1 month ago
5 views
Shared 4 months ago
109 views
Shared 8 months ago
106 views
Shared 8 months ago
176 views
Shared 8 months ago
125 views
Shared 8 months ago
83 views
Shared 8 months ago
61 views
Shared 8 months ago
33 views
Shared 8 months ago
120 views
Shared 8 months ago
49 views
Shared 8 months ago
114 views
Shared 9 months ago
250 views
Shared 9 months ago
63 views
Shared 9 months ago
48 views
A Global Village for Global Impact: Talk with Michael Altorfer, CEO of the Swiss Biotech Association
Shared 9 months ago
60 views
Shared 9 months ago
53 views
Shared 3 years ago
33 views
Shared 3 years ago
110 views
Shared 3 years ago
49 views
Shared 3 years ago
55 views
Shared 3 years ago
13 views
Shared 3 years ago
34 views
Shared 3 years ago
12 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy (Christopher Missling)
Shared 3 years ago
192 views
Shared 3 years ago
10 views
Shared 3 years ago
57 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy Adrian Newman-Tancredi
Shared 3 years ago
12 views
Shared 3 years ago
41 views
Shared 3 years ago
45 views
Shared 3 years ago
25 views
Shared 3 years ago
8 views
Shared 3 years ago
13 views
Shared 3 years ago
12 views
Shared 3 years ago
8 views
Shared 3 years ago
34 views
Shared 3 years ago
59 views
Shared 3 years ago
6 views
Shared 3 years ago
21 views
Shared 3 years ago
5 views
Shared 3 years ago
6 views
Shared 3 years ago
14 views